As drug developers seek out novel solutions for geriatric and pediatric populations and patients with difficulty swallowing ...

Axplora’s Chasse-sur-Rhône CDMO site in France has successfully passed its latest on-site inspection by the ANSM.

TriLink BioTechnologies, a provider of life science reagents and services, has signed a non-exclusive License and Supply ...

BioNTech SE and BMS have partnered for the global co-development and co-commercialization of BNT327 across numerous solid ...

Zydus Lifesciences Ltd. plans to enter the global biologics contract development and manufacturing organization (CDMO) ...

Cellares, a pioneer in automated cell therapy manufacturing, is establishing a next-gen commercial production site for CAR-T ...

FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences and FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM ...

Sterling will manufacture cGMP clinical material for KIVU-107 at its bioconjugation facility in Deeside, UK. Kivu Bioscience, ...

PharmaLogic Holdings Corp., a CDMO specialized in radiopharmaceuticals, has appointed Etienne Montagut, currently serving as ...

Aims to advance cutaneous drug delivery into the skin for Epidermolysis Bullosa. DEBRA Research GmbH, a global non-profit ...

Sanofi has entered into an agreement to acquire Blueprint Medicines Corp., a U.S.-based biopharma company specializing in ...

The CDMO's head of development talks about ADCs, accelerated timelines, and the push for end-to-end development services.